Christina Albertin
University of Rochester
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Christina Albertin.
Pediatrics | 2007
Cynthia M. Rand; Peter G. Szilagyi; Christina Albertin; Peggy Auinger
OBJECTIVE. We estimated the additional number of primary care visits needed to deliver 3 doses of human papillomavirus vaccine to all US adolescents in medical homes. We determined adolescent and family factors associated with needing the greatest number of additional visits for full human papillomavirus vaccination. METHODS. We performed a cross-sectional analysis of adolescents 11 to 21 years of age included in the 2002 and 2003 Medical Expenditure Panel Surveys (n = 2900) to measure existing primary care visits to pediatricians, family physicians, obstetrician/gynecologists, and internists. We then estimated additional visits needed for human papillomavirus vaccination. We determined the number of additional visits needed within a 6-, 12-, 18-, or 24-month vaccination window. RESULTS. Within a 12-month period, 72% of female adolescents would need 3 visits for human papillomavirus vaccination if the vaccine was introduced at a preventive visit; 9% and 16% would need 1 and 2 more visits, respectively. Similarly, 79% of male patients would need 3 visits; 7% and 12% would need 1 and 2 more visits, respectively. If all opportunities to vaccinate were used, then 41% of female patients and 52% of male patients would need 3 additional visits within 12 months. With expansion of the window to 24 months and vaccination at every possible visit, 23% of female patients and 37% of male patients would need 3 additional visits. Factors that predicted needing more visits (2 or 3 vs 0 or 1 in 24 months) included being older, male, black, Hispanic, uninsured, and near-poor. CONCLUSIONS. Most adolescents would require 2 or 3 additional primary care visits to receive 3 vaccines for human papillomavirus in the medical home. Strategies to minimize additional visits include vaccinating patients at all primary care visits and encouraging annual preventive visits.
Academic Pediatrics | 2013
Peter G. Szilagyi; Christina Albertin; Sharon G. Humiston; Cynthia M. Rand; Stanley J. Schaffer; Howard Brill; Joseph Stankaitis; Byung Kwang Yoo; Aaron K. Blumkin; Shannon Stokley
OBJECTIVE To assess the impact of a managed care-based patient reminder/recall system on immunization rates and preventive care visits among low-income adolescents. METHODS We conducted a randomized controlled trial between December 2009 and December 2010 that assigned adolescents aged 11-17 years to one of three groups: mailed letter, telephone reminders, or control. Publicly insured youths (n = 4115) were identified in 37 participating primary care practices. The main outcome measures were immunization rates for routine vaccines (meningococcus, pertussis, HPV) and preventive visit rates at study end. RESULTS Intervention and control groups were similar at baseline for demographics, immunization rates, and preventive visits. Among adolescents who were behind at the start, immunization rates at study end increased by 21% for mailed (P < .01 vs control), 17% for telephone (P < .05), and 13% for control groups. The proportion of adolescents with a preventive visit (within 12 months) was: mailed (65%; P < .01), telephone (63%; P < .05), and controls (59%). The number needed to treat for an additional fully vaccinated adolescent was 14 for mailed and 25 for telephone reminders; for an additional preventive visit, it was 17 and 29. The intervention cost
JAMA Pediatrics | 2011
Peter G. Szilagyi; Sharon G. Humiston; Sarah Gallivan; Christina Albertin; Martha Sandler; Aaron K. Blumkin
18.78 (mailed) or
JAMA Pediatrics | 2008
Cynthia M. Rand; Peter G. Szilagyi; Byung Kwang Yoo; Peggy Auinger; Christina Albertin; Margaret S. Coleman
16.68 (phone) per adolescent per year to deliver. The cost per additional adolescent fully vaccinated was
Clinical Pediatrics | 2011
Cynthia M. Rand; Stanley J. Schaffer; Sharon G. Humiston; Christina Albertin; Laura P. Shone; Eric V. Heintz; Aaron K. Blumkin; Shannon Stokley; Peter G. Szilagyi
463.99 for mailed and
Journal of Adolescent Health | 2015
Cynthia M. Rand; Howard Brill; Christina Albertin; Sharon G. Humiston; Stanley J. Schaffer; Laura P. Shone; Aaron K. Blumkin; Peter G. Szilagyi
714.98 for telephone; the cost per additional adolescent receiving a preventive visit was
Pediatrics | 2013
Anne-Marie Conn; Moira Szilagyi; Todd Franke; Christina Albertin; Aaron K. Blumkin; Peter G. Szilagyi
324.75 and
Pediatrics | 2016
Peter G. Szilagyi; Stanley J. Schaffer; Cynthia M. Rand; Phyllis Vincelli; Ashley Eagan; Nicolas P.N. Goldstein; A. Dirk Hightower; Mary Younge; Aaron K. Blumkin; Christina Albertin; Byung Kwang Yoo; Sharon G. Humiston
487.03. CONCLUSIONS Managed care-based mail or telephone reminder/recall improved adolescent immunizations and preventive visits, with modest costs and modest impact.
Pediatrics | 2018
Cynthia M. Rand; Stanley J. Schaffer; Nui Dhepyasuwan; Aaron K. Blumkin; Christina Albertin; Janet R. Serwint; Paul M. Darden; Sharon G. Humiston; Keith J. Mann; William Stratbucker; Peter G. Szilagyi
OBJECTIVE To assess the impact of a tiered patient immunization navigator intervention (immunization tracking, reminder/recall, and outreach) on improving immunization and preventive care visit rates in urban adolescents. DESIGN Randomized clinical trial allocating adolescents (aged 11-15 years) to intervention vs standard of care control. SETTING Eight primary care practices. PARTICIPANTS Population-based sample of adolescents (N = 7546). INTERVENTION Immunization navigators at each practice implemented a tiered protocol: immunization tracking, telephone or mail reminder/recall, and home visits if participants remained unimmunized or behind on preventive care visits. MAIN OUTCOME MEASURES Immunization rates at study end. Secondary outcomes were preventive care visit rates during the previous 12 months and costs. RESULTS The intervention and control groups were similar at baseline for demographics (mean age, 13.5 years; 63% black, 14% white, and 23% Hispanic adolescents; and 74% receiving Medicaid), immunization rates, and preventive care visit rates. Immunization rates at the end of the study were 44.7% for the intervention group and 32.4% for the control group (adjusted risk ratio, 1.4; 95% confidence interval, 1.3-1.5); preventive care visit rates were 68.0% for the intervention group and 55.2% for the control group (1.2; 1.2-1.3). Findings were similar across practices, sexes, ages, and insurance providers. The number needed to treat for immunizations and preventive care visits was 9. The intervention cost was
Academic Pediatrics | 2018
Alison Saville; Peter G. Szilagyi; Laura Helmkamp; Christina Albertin; Dennis Gurfinkel; Sitaram Vangela; L. Miriam Dickinson; Xinkai Zhou; Heather Roth; Allison Kempe
3.81 per adolescent per month; the cost per additional adolescent fully vaccinated was
Collaboration
Dive into the Christina Albertin's collaboration.
National Center for Immunization and Respiratory Diseases
View shared research outputs